Related Experiment Video
Updated: Jan 10, 2026

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
Published on: January 27, 2023
Evaluation of Hypertension in Pediatric Hemolytic Uremic Syndrome (A Cross-Sectional Study)
Mahdi Banaei Nourmohammadi1, Fahimeh Askarian2, Arash Abbasi2
1Tehran University of Medical Sciences Tehran Iran.
Insights
Hypertension (HTN) affects nearly half of children with hemolytic uremic syndrome (HUS), a kidney condition. This HTN is linked to heart issues and low potassium, highlighting the need for close monitoring in pediatric HUS patients.
Area of Science:
- Pediatric Nephrology
- Cardiovascular Health in Children
- Critical Care Medicine
Background:
- Hemolytic uremic syndrome (HUS), especially Shiga toxin-producing *Escherichia coli* (STEC)-associated HUS, is a leading cause of acute kidney injury (AKI) in children.
- Hypertension (HTN) is a known complication of HUS, but its prevalence and risk factors in pediatric populations are understudied.
Purpose of the Study:
- To determine the prevalence of HTN in children diagnosed with HUS.
- To identify clinical correlates and potential risk factors associated with HTN in these patients, including laboratory findings and cardiac involvement.
Main Methods:
- A descriptive cross-sectional study involving 50 pediatric HUS patients hospitalized between 2021 and 2024.
- Data collection included blood pressure, BMI, renal function markers, and echocardiographic findings.
- Statistical analysis utilized SPSS v26, employing t-tests, chi-square, and Fisher's exact tests to analyze associations.
Main Results:
- Hypertension (HTN) was present in 48% of the pediatric HUS patients.
- HTN showed significant associations with hypokalemia (p=0.011) and cardiac involvement (p=0.045).
- No significant associations were found between HTN and age, sex, BMI, HUS type, urea, creatinine, or hemoglobin levels.
Conclusions:
- This study underscores the significant prevalence of HTN in pediatric HUS patients.
- HTN in HUS is associated with cardiac complications and electrolyte imbalances, particularly hypokalemia.
- Routine blood pressure monitoring and cardiovascular assessments are crucial for managing pediatric HUS, with recommendations for lifelong follow-up.
Background:
Hemolytic uremic syndrome (HUS), particularly the Shiga toxin-producing Escherichia coli (STEC)-associated subtype, is a major cause of acute kidney injury [AKI] in children. Although hypertension (HTN) is a recognized complication of HUS, its prevalence and related risk factors in these children are particularly poorly studied.
Objectives:
This study is designed to determine the prevalence of HTN among children diagnosed with HUS and to identify its potential clinical correlates, including laboratory parameters and cardiac involvement.
Methods:
A descriptive cross-sectional study was conducted on 50 pediatric patients diagnosed with HUS and hospitalized in our tertiary nephrology ward between 2021 and 2024. Clinical and laboratory data, including blood pressure, BMI, renal function markers, and echocardiographic findings, were extracted from medical records. HTN was defined using the AAP Pediatric HTN calculator. Statistical analysis was performed using SPSS v26 software, t-tests, chi-square, and Fisher's exact test.
Results:
HTN was observed in 48% of our patients. No significant associations were found between HTN and age, sex, BMI, HUS type, urea, creatinine, or hemoglobin levels. However, HTN was significantly associated with hypokalemia (p = 0.011) and cardiac involvement (p = 0.045). Among patients with AKI, 54.2% had HTN; however, this association was not significant (p = 0.402).
Conclusion:
Although this study is a small one and was done in a single center, it supports the importance of HTN in patients with HUS. HTN is quite prevalent among children with HUS and shows a significant association with cardiac complications and electrolyte imbalances. These findings indicate the importance of routine blood pressure monitoring and cardiovascular assessment in the management of pediatric HUS. Lifelong follow-up is recommended for early detection of signs of chronic kidney and cardiovascular sequelae.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
11:27A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Nephrotic Syndrome II : Assessment and Medical Management